Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Pawlowski

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|April 7, 2016
Development of Small Molecules that Specifically Inhibit the D-loop Activity of RAD51Wei Lv, Brian Budke, Michal Pawlowski, et al.
Biomedical Optics Express|September 13, 2021
Ultrafast laser surgery probe with a calcium fluoride miniaturized objective for bone ablationKaushik Subramanian, Liam Andrus, Michal Pawlowski, et al.
Optical Engineering (Redondo Beach, Calif.)|June 6, 2017
Design and fabrication of a miniature objective consisting of high refractive index zinc sulfide lenses for laser surgeryAdam Shadfan, Michal Pawlowski, Ye Wang, et al.
Biomedical Optics Express|November 30, 2016
Kagome fiber based ultrafast laser microsurgery probe delivering micro-Joule pulse energiesKaushik Subramanian, Ilan Gabay, Onur Ferhanoğlu, et al.
Journal of Medicinal Chemistry|December 13, 2012
An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivityBrian Budke, Jay H Kalin, Michal Pawlowski, et al.
Scientific Reports|November 29, 2022
Ultrafast laser surgery probe for sub-surface ablation to enable biomaterial injection in vocal foldsLiam Andrus, Hamin Jeon, Michal Pawlowski, et al.
Lab on a Chip|May 9, 2013
Chromatography paper as a low-cost medium for accurate spectrophotometric assessment of blood hemoglobin concentrationMeaghan Bond, Carlos Elguea, Jasper S Yan, et al.
Nature Communications|October 4, 2012
Robust photoregulation of GABA(A) receptors by allosteric modulation with a propofol analogueLan Yue, Michal Pawlowski, Shlomo S Dellal, et al.
Cancer Research|April 23, 2014
The RAD51-stimulatory compound RS-1 can exploit the RAD51 overexpression that exists in cancer cells and tumorsJennifer M Mason, Hillary L Logan, Brian Budke, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|April 7, 2016
Development of Small Molecules that Specifically Inhibit the D-loop Activity of RAD51Wei Lv, Brian Budke, Michal Pawlowski, et al.
Biomedical Optics Express|September 13, 2021
Ultrafast laser surgery probe with a calcium fluoride miniaturized objective for bone ablationKaushik Subramanian, Liam Andrus, Michal Pawlowski, et al.
Optical Engineering (Redondo Beach, Calif.)|June 6, 2017
Design and fabrication of a miniature objective consisting of high refractive index zinc sulfide lenses for laser surgeryAdam Shadfan, Michal Pawlowski, Ye Wang, et al.
Biomedical Optics Express|November 30, 2016
Kagome fiber based ultrafast laser microsurgery probe delivering micro-Joule pulse energiesKaushik Subramanian, Ilan Gabay, Onur Ferhanoğlu, et al.
Journal of Medicinal Chemistry|December 13, 2012
An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivityBrian Budke, Jay H Kalin, Michal Pawlowski, et al.
Scientific Reports|November 29, 2022
Ultrafast laser surgery probe for sub-surface ablation to enable biomaterial injection in vocal foldsLiam Andrus, Hamin Jeon, Michal Pawlowski, et al.
Lab on a Chip|May 9, 2013
Chromatography paper as a low-cost medium for accurate spectrophotometric assessment of blood hemoglobin concentrationMeaghan Bond, Carlos Elguea, Jasper S Yan, et al.
Nature Communications|October 4, 2012
Robust photoregulation of GABA(A) receptors by allosteric modulation with a propofol analogueLan Yue, Michal Pawlowski, Shlomo S Dellal, et al.
Cancer Research|April 23, 2014
The RAD51-stimulatory compound RS-1 can exploit the RAD51 overexpression that exists in cancer cells and tumorsJennifer M Mason, Hillary L Logan, Brian Budke, et al.
Pageof 1